Condition: Patient Preference · Sponsor: Ophthalmic Consultants of Long Island
To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
This description comes directly from the study's public registry record.
Erin Loweree · 516-593-4026 · eloweree@ocli.net
Isabel Lezcano · 516-593-4026 · ilezcano@ocli.net
Always discuss trial participation with your own doctor first.
| Ophthalmic Consultants of Long Island | Garden City, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04205916